Skip to main content
TASLY PHARMACEUTICAL GROUP CO.,LTD. logo

TASLY PHARMACEUTICAL GROUP CO.,LTD. — Investor Relations & Filings

Ticker · 600535 ISIN · CNE000001C81 LEI · 300300JB9F71F58FIC88 Shanghai Stock Exchange Manufacturing
Filings indexed 1,889 across all filing types
Latest filing 2024-08-30 AGM Information
Country CN China
Listing Shanghai Stock Exchange 600535

About TASLY PHARMACEUTICAL GROUP CO.,LTD.

http://www.tasly.com

Tasly Pharmaceutical Group Co., Ltd. specializes in the research, development, and production of modern Traditional Chinese Medicine (TCM), biological products, and chemical pharmaceuticals. The company is primarily known for its flagship cardiovascular treatment, Compound Danshen Dripping Pills, which represents a significant advancement in the modernization and standardization of herbal medicine. Its therapeutic portfolio covers cardiovascular, cerebrovascular, digestive, and metabolic diseases, as well as oncology. Tasly utilizes high-tech manufacturing processes and maintains a strong focus on R&D to bridge traditional therapies with modern clinical standards. The organization also explores digital health solutions and innovative drug delivery systems to enhance its comprehensive healthcare offerings.

Recent filings

Filing Released Lang Actions
天士力2024年第二次临时股东大会会议资料
AGM Information Classification · 95% confidence The document is titled '2024年第二次临时股东大会会议资料' which translates to '2024 Second Extraordinary General Meeting (EGM) Meeting Materials'. It contains detailed agenda items, voting methods, attendance information, and a specific proposal regarding the 2024 half-year profit distribution plan. The document is a set of materials prepared for the shareholders' meeting, including the agenda, voting procedures, and proposal details, but it is not the minutes or the voting results themselves. The document length is 2707 characters, which is relatively short and consistent with meeting materials rather than a full report. This matches the definition of AGM Information (AGM-R), which includes presentations and materials shared during the Annual or Extraordinary General Meeting. It is not an announcement of voting results (DVA), nor a full annual or interim report, nor a proxy statement. Therefore, the best classification is AGM Information (AGM-R).
2024-08-30 Chinese
天士力关于参加2024年度天津辖区上市公司半年报业绩说明会暨投资者网上集体接待日活动的公告
Investor Presentation Classification · 90% confidence The document is an announcement about the company's participation in a half-year performance explanation meeting and an investor online reception day. It mentions the event date, participation details, and the executives who will attend to discuss company performance and governance. The document does not contain actual financial statements or detailed financial analysis but rather informs about an upcoming event related to the interim report. The document length is short (794 characters), and it serves as a notice for an investor presentation event rather than the report itself. Therefore, it fits best under the category of Investor Presentation (IP).
2024-08-28 Chinese
天士力第九届监事会第2次会议决议公告
Regulatory Filings Classification · 95% confidence The document is a resolution announcement from the Supervisory Board of a company regarding the approval of the 2024 semi-annual report, related investment transactions, and a profit distribution plan. It references the 2024 semi-annual report but does not contain the report itself, only the Supervisory Board's review and approval of it. The document is short (1184 characters) and serves as an official announcement of decisions made in a board meeting rather than the full financial report. Therefore, it fits best as a Regulatory Filing (RNS) since it is a formal announcement related to corporate governance and report approval but not the report itself.
2024-08-23 Chinese
2024年第二次独立董事专门会议决议
Board/Management Information Classification · 95% confidence The document is a resolution from the independent directors of a company regarding an investment decision and related party transaction. It includes voting results and signatures of independent directors. The content focuses on board-level decision-making and approval of a specific transaction, not on financial results, audit, or general shareholder meeting materials. It is not a full report, earnings release, or regulatory filing. The document fits best under Board/Management Information (MANG) as it relates to board decisions and governance matters.
2024-08-23 Chinese
天士力关于公司2024年半年度主要经营数据的公告
Interim / Quarterly Report Classification · 90% confidence The document is titled as an announcement regarding the company's 2024 half-year main operating data. It contains detailed financial data for the first half of 2024, including revenue, cost, and gross margin by industry, treatment area, product, and region. The document explicitly states that the data is unaudited and is a disclosure of main operating data for the half-year period. The length is 2775 characters, which is relatively short but contains substantive financial data and analysis for the half-year period. It is not a full interim report with comprehensive financial statements but a summary of key operating data for the half-year. According to the definitions, a comprehensive financial report for a period shorter than a full fiscal year with substantive financial data and analysis is classified as an Interim / Quarterly Report (IR). This document fits best as an Interim / Quarterly Report (IR) because it provides half-year operating data with financial metrics and growth rates, not just an announcement or a brief summary. Therefore, the classification is IR with high confidence. H1 2024
2024-08-23 Chinese
天士力2024年半年度利润分配预案
Notice of Dividend Amount Classification · 95% confidence The document is a profit distribution plan for the half-year period ending June 30, 2024, detailing the proposed cash dividend per share, total dividend amount, and the decision-making process including board and supervisory opinions. It is not the full interim financial report but a specific announcement about dividend distribution related to the half-year results. The document length is short (1607 characters) and focuses on dividend distribution details rather than comprehensive financial statements or analysis. Therefore, it fits best under the category of Notice of Dividend Amount (DIV).
2024-08-23 Chinese

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.